Salt and crystal form of egfr inhibitor, and composition and use thereof
US-2024352053-A1 · Oct 24, 2024 · US
Wang Jiabing is listed as an inventor on 10 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Jiabing |
| Total patents | 10 |
| First publication | Jun 30, 2015 |
| Latest publication | Oct 24, 2024 |
Publications ranked by popularity score, then publication date.
US-2024352053-A1 · Oct 24, 2024 · US
US-2024022501-A1 · Jan 18, 2024 · US
US-10484272-B2 · Nov 19, 2019 · US
US-2018016259-A1 · Jan 18, 2018 · US
US-2017264534-A1 · Sep 14, 2017 · US
US-9718806-B2 · Aug 1, 2017 · US
US-2016340342-A1 · Nov 24, 2016 · US
US-9375432-B2 · Jun 28, 2016 · US
US-2015320751-A1 · Nov 12, 2015 · US
US-9066979-B2 · Jun 30, 2015 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astrazeneca Ab | 6 |
| Betta Pharmaceuticals Co Ltd | 1 |
| Hewlett Packard Entpr Dev Lp | 1 |
| Huawei Tech Co Ltd | 1 |
| Hangzhou H3C Tech Co Ltd | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| A61P35/04 | 6 |
| A61P35/02 | 6 |
| C07D403/12 | 6 |
| A61K45/06 | 6 |